Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Representing dynamic biological networks with multi-scale probabilistic models.

Groß A, Kracher B, Kraus JM, Kühlwein SD, Pfister AS, Wiese S, Luckert K, Pötz O, Joos T, Van Daele D, De Raedt L, Kühl M, Kestler HA.

Commun Biol. 2019 Jan 17;2:21. doi: 10.1038/s42003-018-0268-3. eCollection 2019.

2.

Temporal quantitative phosphoproteomics of ADP stimulation reveals novel central nodes in platelet activation and inhibition.

Beck F, Geiger J, Gambaryan S, Solari FA, Dell'Aica M, Loroch S, Mattheij NJ, Mindukshev I, Pötz O, Jurk K, Burkhart JM, Fufezan C, Heemskerk JW, Walter U, Zahedi RP, Sickmann A.

Blood. 2017 Jan 12;129(2):e1-e12. doi: 10.1182/blood-2016-05-714048. Epub 2016 Nov 9.

3.

Hepatotoxic effects of cyproconazole and prochloraz in wild-type and hCAR/hPXR mice.

Marx-Stoelting P, Ganzenberg K, Knebel C, Schmidt F, Rieke S, Hammer H, Schmidt F, Pötz O, Schwarz M, Braeuning A.

Arch Toxicol. 2017 Aug;91(8):2895-2907. doi: 10.1007/s00204-016-1925-2. Epub 2017 Jan 6.

PMID:
28058446
4.

Bulk cell density and Wnt/TGFbeta signalling regulate mesendodermal patterning of human pluripotent stem cells.

Kempf H, Olmer R, Haase A, Franke A, Bolesani E, Schwanke K, Robles-Diaz D, Coffee M, Göhring G, Dräger G, Pötz O, Joos T, Martinez-Hackert E, Haverich A, Buettner FFR, Martin U, Zweigerdt R.

Nat Commun. 2016 Dec 9;7:13602. doi: 10.1038/ncomms13602.

5.

A Nexus Consisting of Beta-Catenin and Stat3 Attenuates BRAF Inhibitor Efficacy and Mediates Acquired Resistance to Vemurafenib.

Sinnberg T, Makino E, Krueger MA, Velic A, Macek B, Rothbauer U, Groll N, Pötz O, Czemmel S, Niessner H, Meier F, Ikenberg K, Garbe C, Schittek B.

EBioMedicine. 2016 Jun;8:132-149. doi: 10.1016/j.ebiom.2016.04.037. Epub 2016 May 1.

6.

Innate immune system favors emergency monopoiesis at the expense of DC-differentiation to control systemic bacterial infection in mice.

Pasquevich KA, Bieber K, Günter M, Grauer M, Pötz O, Schleicher U, Biedermann T, Beer-Hammer S, Bühring HJ, Rammensee HG, Zender L, Autenrieth IB, Lengerke C, Autenrieth SE.

Eur J Immunol. 2015 Oct;45(10):2821-33. doi: 10.1002/eji.201545530. Epub 2015 Jul 24.

7.

Systematic reference sample generation for multiplexed serological assays.

Planatscher H, Rimmele S, Michel G, Pötz O, Joos T, Schneiderhan-Marra N.

Sci Rep. 2013 Nov 19;3:3259. doi: 10.1038/srep03259.

8.

Release of matrix metalloproteinase-8 during physiological trafficking and induced mobilization of human hematopoietic stem cells.

Steinl C, Essl M, Schreiber TD, Geiger K, Prokop L, Stevanović S, Pötz O, Abele H, Wessels JT, Aicher WK, Klein G.

Stem Cells Dev. 2013 May 1;22(9):1307-18. doi: 10.1089/scd.2012.0063. Epub 2013 Feb 12.

9.

Concurrent epigenetic silencing of wnt/β-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia.

Moskalev EA, Luckert K, Vorobjev IA, Mastitsky SE, Gladkikh AA, Stephan A, Schrenk M, Kaplanov KD, Kalashnikova OB, Pötz O, Joos TO, Hoheisel JD.

BMC Cancer. 2012 Jun 6;12:213. doi: 10.1186/1471-2407-12-213.

10.

Combining ultracentrifugation and peptide termini group-specific immunoprecipitation for multiplex plasma protein analysis.

Volk S, Schreiber TD, Eisen D, Wiese C, Planatscher H, Pynn CJ, Stoll D, Templin MF, Joos TO, Pötz O.

Mol Cell Proteomics. 2012 Jul;11(7):O111.015438. doi: 10.1074/mcp.O111.015438. Epub 2012 Apr 23.

11.

A dual array-based approach to assess the abundance and posttranslational modification state of signaling proteins.

Luckert K, Gujral TS, Chan M, Sevecka M, Joos TO, Sorger PK, Macbeath G, Pötz O.

Sci Signal. 2012 Jan 10;5(206):pl1. doi: 10.1126/scisignal.2002372. Erratum in: Sci Signal. 2012 Aug 21;5(238):er5. Sevecka, Mark [added].

12.

Receptor tyrosine kinase inhibitor profiling using bead-based multiplex sandwich immunoassays.

Pötz O, Schneiderhan-Marra N, Henzler T, Herget T, Joos TO.

Methods Mol Biol. 2012;795:191-202. doi: 10.1007/978-1-61779-337-0_13.

PMID:
21960224
13.

Sandwich immunoassay for soluble glycoprotein VI in patients with symptomatic coronary artery disease.

Bigalke B, Pötz O, Kremmer E, Geisler T, Seizer P, Puntmann VO, Phinikaridou A, Chiribiri A, Nagel E, Botnar RM, Joos T, Gawaz M.

Clin Chem. 2011 Jun;57(6):898-904. doi: 10.1373/clinchem.2010.158527. Epub 2011 Apr 7.

14.

Snapshots of protein dynamics and post-translational modifications in one experiment--beta-catenin and its functions.

Luckert K, Götschel F, Sorger PK, Hecht A, Joos TO, Pötz O.

Mol Cell Proteomics. 2011 May;10(5):M110.007377. doi: 10.1074/mcp.M110.007377. Epub 2011 Mar 4.

15.

Protein-protein-interactions in a multiplexed, miniaturized format a functional analysis of Rho GTPase activation and inhibition.

Schmohl M, Rimmele S, Pötz O, Kloog Y, Gierschik P, Joos TO, Schneiderhan-Marra N.

Proteomics. 2010 Apr;10(8):1716-20. doi: 10.1002/pmic.200900597.

PMID:
20127689
16.

Analysis of non-canonical fibroblast growth factor receptor 1 (FGFR1) interaction reveals regulatory and activating domains of neurofascin.

Kirschbaum K, Kriebel M, Kranz EU, Pötz O, Volkmer H.

J Biol Chem. 2009 Oct 16;284(42):28533-42. doi: 10.1074/jbc.M109.004440. Epub 2009 Aug 7.

17.

Influence of platelet count on the expression of platelet collagen receptor glycoprotein VI (GPVI) in patients with acute coronary syndrome.

Bigalke B, Stellos K, Stakos D, Joos T, Pötz O, Geisler T, Bischofs C, Kremmer E, Krämer BF, Seizer P, May AE, Lindemann S, Gawaz M.

Thromb Haemost. 2009 May;101(5):911-5.

PMID:
19404545
18.

Regulation of platelet glycoprotein VI (GPVI) surface expression and of soluble GPVI in patients with atrial fibrillation (AF) and acute coronary syndrome (ACS).

Bigalke B, Stellos K, Weig HJ, Geisler T, Seizer P, Kremmer E, Pötz O, Joos T, May AE, Lindemann S, Gawaz M.

Basic Res Cardiol. 2009 May;104(3):352-7. doi: 10.1007/s00395-009-0779-7. Epub 2009 Feb 3.

PMID:
19190951
19.

Protein microarrays: promising tools for proteomic research.

Templin MF, Stoll D, Schwenk JM, Pötz O, Kramer S, Joos TO.

Proteomics. 2003 Nov;3(11):2155-66. Review.

PMID:
14595815

Supplemental Content

Support Center